Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy

Filipe Elvas1, Tom Vanden Berghe, Yves Adriaenssens

  • 1Molecular Imaging Center Antwerp, University of Antwerp, 2610 Wilrijk, Belgium. filipe.elvas@uantwerpen.be.

Insights

Researchers developed a new PET imaging probe, [18F]MICA-302, to detect apoptosis by targeting active caspase-3. This tool could help assess anticancer therapy effectiveness non-invasively in patients.

Area of Science:

  • Molecular Imaging
  • Oncology
  • Biochemistry

Background:

  • Apoptosis is crucial for development and homeostasis, and its induction is a key goal in cancer therapy.
  • Caspase activation, particularly caspase-3 and -7, is a central event in apoptosis and a potential biomarker for treatment response.
  • Non-invasive in vivo imaging of apoptosis can enable early assessment of therapeutic efficacy and drug development.

Purpose of the Study:

  • To develop and evaluate novel fluorine-18-labeled caspase-3 activity-based probes (ABPs) for Positron Emission Tomography (PET) imaging of apoptosis.
  • To identify a suitable ABP with high affinity for caspase-3 and favorable properties for in vivo imaging.
  • To assess the potential of the developed radiotracer for monitoring response to anticancer therapy.

Main Methods:

  • Screening of fluorine-19-labeled DEVD peptides with different electrophilic warheads to identify high-affinity ABPs.
  • Radiolabeling of the lead compound with fluorine-18 to create the PET tracer [18F]MICA-302.
  • In vitro evaluation of [18F]MICA-302 for caspase-3 labeling and pharmacokinetic profiling.
  • In vivo microPET imaging in colorectal tumor xenografts to assess tumor accumulation in response to drug treatment.

Main Results:

  • An acyloxymethyl ketone-containing DEVD peptide was identified with low nanomolar affinity for caspase-3.
  • [18F]MICA-302 demonstrated effective labeling of active caspase-3 in vitro and favorable pharmacokinetic properties.
  • μPET imaging revealed increased tumor accumulation of [18F]MICA-302 in drug-treated tumor xenografts compared to controls.

Conclusions:

  • The developed fluorine-18-labeled ABP, [18F]MICA-302, shows promise for PET imaging of apoptosis.
  • This radiotracer may serve as a valuable tool for non-invasive, in vivo assessment of response to anticancer therapies.
  • Further clinical evaluation is warranted to establish its utility in patient management and drug development.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.4K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.0K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
403